$ Value
—
Shares
2,662
Price
—
Filed
Jun 9
Insider
Name
Maunsell Farris Maryanne
Title
VP, Chief Accounting Officer
CIK
0001950052
Roles
Transaction Details
Transaction Date
2025-06-05
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
4,478
Footnotes
The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. Two-thirds of the RSUs vest in two equal annual installments beginning on the first anniversary of the date of grant and one-third of the RSUs vests based on the Issuer's common stock price at the end of a two-year performance period. | Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. | This number includes unvested RSUs previously reported.